UK tribunal correctly analyzed ‘clear-cut’ drug pricing case, CMA says
The UK's Competition Appeal Tribunal correctly analyzed an antitrust infringement case that targeted a clutch of drugmakers over their commercial practices in supplying hydrocortisone tablets, the Competition and Markets Authority told...To view the full article, register now.
Already a subscriber? Click here to view full article